6/27/2007 | PP | Market Commentary: ISTA secures $36.75 million from stock sale; Organic To Go cooks up $6.35 million offering
|
6/25/2007 | PP | Market Commentary: Celsius obtains $16 million equity line; Twin Butte prices C$18 million offering
|
6/22/2007 | PP | Market Commentary: Metalico to pocket $36.72 million from stock; Targeted Genetics secures $19.43 million
|
6/22/2007 | PP | New Issue: Targeted Genetics to complete $19.5 million placement of shares
|
1/10/2007 | PP | Market Commentary: Empire Energy raises $4 million from loan with warrants; Strategic Nevada prices C$6.25 million deal
|
1/9/2007 | PP | Market Commentary: Denison Mines digs up C$105.88 million from stock sale; Homburg secures C$32.6 million from PIPE
|
1/8/2007 | PP | New Issue: Targeted Genetics secures $8.72 million from stock offering
|
1/8/2007 | PP | Market Commentary: International Stem Cell picks up $11.2 million from stock sale; Targeted Genetics raises $8.72 million
|
11/10/2006 | BT | Market Commentary: Tanox soars 45% on Genentech buy; Targeted Genetics adds 26%, Pozen higher; Insmed, Tercica better
|
11/8/2006 | BT | Targeted Genetics' net loss improves, company on track to meet full-year operating forecast
|
11/7/2006 | BT | Market Commentary: Catalyst cuts IPO price in half; Cytogen off on PIPE; Targeted Genetics gains 35%; Iomai better
|
11/7/2006 | BT | Targeted Genetics amends Biogen Idec funding agreement, will repay $500,000 in stock
|
9/14/2006 | BT | Targeted Genetics gets patent to protect composition of AAV vectors
|
8/30/2006 | BT | Targeted Genetics notes modest immune response in HIV vaccine trial; to release interim results
|
8/10/2006 | BT | Targeted Genetics to consider collaborations, strategic transactions for raising capital
|
6/28/2006 | BT | Targeted Genetics to issue shares for AIDS vaccine development
|
6/22/2006 | BT | Targeted Genetics: interim data supports safety, tolerability of tgAAC94 in inflammatory arthritis
|
6/5/2006 | BT | Targeted Genetics reports tgAAC94 reduces swelling, tenderness in inflammatory arthritis
|
6/1/2006 | BT | Market Commentary: Targeted Genetics' stock jumps 18% on promising data; Endologix raises $20.13 million from stock sale
|
6/1/2006 | BT | Targeted Genetics interim study data says tgAAC94 improves arthritis symptoms
|
5/9/2006 | BT | Targeted Genetics shareholders authorize reverse stock split
|
4/26/2006 | BT | Targeted Genetics collaborates on preventive HIV vaccine trial in Zambia
|
3/16/2006 | BT | Targeted Genetics ups dose, target enrollment for tgAAC94 arthritis trial
|
3/10/2006 | BTPP | New Issue: Targeted Genetics prepares to close $4.98 million direct placement of stock
|
3/10/2006 | PP | Market Commentary: Grove Energy prices $15 million convertibles; Targeted Genetics stock sinks on $4.98 million offering
|
3/8/2006 | BT | Targeted Genetics signs subcontract with Children's Hospital of Philadelphia for AIDS vaccine candidate
|
2/10/2006 | BT | Targeted Genetics issued patent for AAV vector manufacturing processes
|
1/24/2006 | BT | Targeted Genetics restructures to advance arthritis product, cut expenses
|
11/14/2005 | BT | Targeted Genetics begins phase 2 HIV vaccine trial
|
10/31/2005 | BT | Targeted Genetics' data shows tgAAC94 eases swelling in arthritic joints
|
9/1/2005 | BT | Targeted Genetics amends Biogen funding agreement, pushing out debt repayments
|